[go: up one dir, main page]

EA201991504A1 - COMPOSITIONS BASED ON AMINO ACIDS AND METHODS FOR TREATING DISEASES AND DISORDERS OF MUSCLES - Google Patents

COMPOSITIONS BASED ON AMINO ACIDS AND METHODS FOR TREATING DISEASES AND DISORDERS OF MUSCLES

Info

Publication number
EA201991504A1
EA201991504A1 EA201991504A EA201991504A EA201991504A1 EA 201991504 A1 EA201991504 A1 EA 201991504A1 EA 201991504 A EA201991504 A EA 201991504A EA 201991504 A EA201991504 A EA 201991504A EA 201991504 A1 EA201991504 A1 EA 201991504A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
muscles
disorders
amino acids
treating diseases
Prior art date
Application number
EA201991504A
Other languages
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/067368 external-priority patent/WO2018118957A1/en
Publication of EA201991504A1 publication Critical patent/EA201991504A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение предусматривает композиции, содержащие структурные единицы на основе аминокислоты. Настоящее изобретение также предусматривает способы повышения функции мышцы, предусматривающие введение эффективного количества композиций субъекту, нуждающемуся в этом.The present invention provides compositions containing amino acid-based structural units. The present invention also provides methods for enhancing muscle function, comprising administering an effective amount of the compositions to a subject in need thereof.

EA201991504A 2017-10-24 2017-12-19 COMPOSITIONS BASED ON AMINO ACIDS AND METHODS FOR TREATING DISEASES AND DISORDERS OF MUSCLES EA201991504A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762576321P 2017-10-24 2017-10-24
PCT/US2017/067368 WO2018118957A1 (en) 2016-12-19 2017-12-19 Amino acid compositions and methods for the treatment of muscle diseases and disorders

Publications (1)

Publication Number Publication Date
EA201991504A1 true EA201991504A1 (en) 2019-11-29

Family

ID=68653577

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991504A EA201991504A1 (en) 2017-10-24 2017-12-19 COMPOSITIONS BASED ON AMINO ACIDS AND METHODS FOR TREATING DISEASES AND DISORDERS OF MUSCLES

Country Status (1)

Country Link
EA (1) EA201991504A1 (en)

Similar Documents

Publication Publication Date Title
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201991720A1 (en) ANTIBODIES TO ALPHA-SINUCLEIN AND THEIR APPLICATIONS
EA201792573A1 (en) TRISPECIFIC RELATED PROTEINS AND METHODS OF THEIR APPLICATION
MX2023007212A (en) EPINEPHRINE SPRAY FORMULATIONS.
ECSP20011578A (en) AMINO ACID COMPOSITIONS FOR THE TREATMENT OF LIVER DISEASE
EA036102B9 (en) Glycotargeting therapeutics
EA202091482A1 (en) ANTIBODIES
EA201891727A1 (en) COMPOSITIONS ON THE BASIS OF DEUTERATED DOMPERIDON AND METHODS OF TREATMENT OF DISORDERS
MX373409B (en) COMPOSITIONS FOR KERATIN FIBERS.
EA201591507A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM
EA201790336A1 (en) ANTIBODIES TO ANGIOPOETHIN-LIKE PROTEIN 4 AND METHODS OF APPLICATION
EA202191446A1 (en) COMPOSITIONS FOR IMPROVING SEXUAL FUNCTIONS
EA202190504A1 (en) METHODS FOR TREATMENT OF PSORIASIS
EA202092045A1 (en) TREATMENT AND PREVENTION OF PREECLAMPSIA
WO2015188198A3 (en) Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
EA201991504A1 (en) COMPOSITIONS BASED ON AMINO ACIDS AND METHODS FOR TREATING DISEASES AND DISORDERS OF MUSCLES
EA202190626A2 (en) COMBINATION OF TRAZODONE AND GABAPENTIN FOR PAIN TREATMENT
EA201991395A1 (en) NEW COMPOSITIONS FOR TREATMENT OF JOINT VIOLATIONS
EA202091524A1 (en) INHIBITORS OF THE PROTEASE 2 ACTIVATED RECEPTOR
EA201991502A1 (en) AMINO ACID COMPOSITIONS AND METHODS FOR TREATMENT OF LIVER DISEASES
EA201592012A1 (en) APPLICATION OF FLAGELLIN FOR IMPROVED CHEMOTHERAPY
EA201991135A1 (en) COMBINED THERAPY BY ARGINASE INHIBITORS
EA201990261A1 (en) 2,5-DUB-SUBSTITUTED 3-METHYL-PYRASINES and 2,5,6-triple-substituted 3-METHYL-PYRASINES AS SHP2 ALLOSTERIC INHIBITORS